ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 135 out of 783

$813K Total Retail Price of All Prescriptions

Rank: 92 out of 783

550 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 647 595 1 3
HYDROCODONE-ACETAMINOPHEN 611 477 S3 2 2
LEVOTHYROXINE SODIUM 507 395 3 1
LISINOPRIL 410 334 4 4
CARVEDILOL 367 312 5 21
FUROSEMIDE 321 279 6 7
AMLODIPINE BESYLATE 298 274 7 5
GABAPENTIN 292 234 8 15
CRESTOR 281 242 9 27
OMEPRAZOLE 280 240 10 6
LOSARTAN POTASSIUM 256 225 11 18
METFORMIN HCL 230 188 12 8
ATORVASTATIN CALCIUM 192 170 13 11
METOPROLOL TARTRATE 177 145 14 9
ZOLPIDEM TARTRATE 175 131 15 23
MELOXICAM 158 117 16 37
CYMBALTA 157 109 17 35
ATENOLOL 151 120 18 17
SERTRALINE HCL 146 111 19 22
LOSARTAN-HYDROCHLOROTHIAZIDE 140 109 20 53
FENOFIBRATE 133 111 21 66
DOXAZOSIN MESYLATE 130 125 22 87
FLUOXETINE HCL 114 79 23 45
CITALOPRAM HBR 112 100 24 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 83 25 33
GLIMEPIRIDE 101 70 26 34
ADVAIR DISKUS 98 78 27 50
EVISTA 95 94 28 92
NEXIUM 90 70 29 28
WARFARIN SODIUM 89 71 30 10
TAMSULOSIN HCL 87 73 31 26
ALENDRONATE SODIUM 85 83 32 25
ALLOPURINOL 84 73 33 31
HYDRALAZINE HCL 82 68 34 78
LEVEMIR FLEXPEN 81 41 35 155
PRAVASTATIN SODIUM 78 63 36 14
TRIAMTERENE-HCTZ 78 68 36 42
TORSEMIDE 77 59 38 126
JANUVIA 75 70 39 73
METOPROLOL SUCCINATE 74 49 40 13
OXYCODONE HCL-ACETAMINOPHEN 72 42 S2 41 86
TRAZODONE HCL 71 43 42 39
PREDNISONE 71 58 42 36
KLOR-CON M20 69 64 44 48
HYDROCHLOROTHIAZIDE 65 60 45 12
CLONIDINE HCL 64 56 46 60
NOVOLOG FLEXPEN 63 29 47 142
DICLOFENAC SODIUM 63 63 47 139
VERAPAMIL ER 62 60 49 119
PLAVIX 61 55 50 51
CLOPIDOGREL 60 50 51 29
POTASSIUM CHLORIDE 58 36 52 16
SYNTHROID 57 54 53 47
OXYCODONE-ACETAMINOPHEN 56 18 S2 54 76
AMITRIPTYLINE HCL 55 45 R 55 77
DIOVAN 53 45 56 49
POLYETHYLENE GLYCOL 3350 52 32 57 43
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 58 83
PROAIR HFA 50 43 59 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.